Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

The HUGO Journal Joins Springer's Biomedical Sciences Portfolio
Starting in October 2009, Springer will publish The HUGO Journal in cooperation with the Human Genome Organisation (HUGO). Formerly published at Springer as Genomic Medicine, The HUGO Journal has a new design, new features and a new editorial team. Members of HUGO will receive free access to the journal online and be able to purchase print subscriptions at discounted rates.
generic viagra online
Bartering For Health Care Increases Amid Economic Woes
Bartering for health care is on the rise as the recession drags on.
News of the day
New Booklet Helps Patients Better Understand Radiation Therapy
The American Society for Radiation Oncology (ASTRO) has recently updated its award-winning patient booklet, Radiation Therapy for Cancer that provides information for people living with cancer and their loved ones who are exploring radiation therapy as a treatment option.
Cardiovascular

Elron Group Company Medingo Receives Formal FDA Clearance To Market Its Insulin Micropump In The United States

Elron Electronic Industries Ltd. (NASDAQ & TASE: ELRN) announced, that further to it previous announcement on July 28, 2009, Medingo Ltd., a group company held 92% by Elron and its subsidiary, RDC - Rafael Development Corporation Ltd., has received formal clearance from the Food and Drug Administration ("FDA"), to market its Solo™ MicroPump Insulin Delivery System in the United States. Medingo intends to introduce the Solo™ MicroPump at the American Association of Diabetes Educators Meeting which will take place in August 2009 in Atlanta, U.S.A. "We are very excited to have received FDA clearance for Medingo"s innovative, miniature, tube-free, insulin delivery system," commented Arie Mientkavich, Chairman of Medingo and Elron. "This is a major milestone for Medingo, which will enable it to progress to the next phase in its development. Medingo is currently considering alternatives for its go-to-market strategy and the timing of the product launch." Elron Electronic Industries Ltd.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009